Molecular dynamics approach to probe PKCβII–ligand interactions and influence of crystal water molecules on these interactions

Bibliography

• Beulens JW, Grobbee DE, Nealb B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil 2010;17:s3-8
   Google Scholar
• Idris I, Gray S, Donnelly R. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 2001;44:659-73
   PubMed Web of Science ®Google Scholar
• Mehta N, Sheetz M, Price K, et al.Selective PKC. Beta Inhibition with Ruboxistaurin and Endothelial Function in Type-2 Diabetes Mellitus. Cardiovasc Drugs Ther 2009;17-17:24
   Google Scholar
• Sledge GW, Gokmen PY. Protein kinase C-beta as a therapeutic target in breast cancer. Semin Oncol 2006;33:15-18
   PubMed Web of Science ®Google Scholar
• Shuyu L, Mark P, Michael L, et al. Retrospective analysis of protein kinase C-beta (PKC-beta) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas. Biol Direct 2007;2:1-13
   Google Scholar
• Huse M, Kuriyan J. The conformational plasticity of protein kinases. Cell 2002;109:275-82
   PubMed Web of Science ®Google Scholar
• Grodsky N, Li Y, Bouzida D, et al. Structure of the catalytic domain of human protein kinase C β II complexed with a bisindolylmaleimide inhibitor. Biochemistry 2006;45:13970-81
   PubMed Web of Science ®Google Scholar
• Leonard TA, Rozycki B, Saidi LF, et al. Crystal Structure and Allosteric Activation of Protein Kinase C βII. Cell 2011;144:55-66
   PubMed Web of Science ®Google Scholar
• Knight JD, Hamelberg D, McCammon JA, et al. The role of conserved water molecules in the catalytic domain of protein kinases. Proteins 2009;76:527-35
   Google Scholar
• Wheeler GD. Ruboxistaurin (Eli Lilly). IDrugs 2003;6:159-63
   PubMedGoogle Scholar
• Liu Y, Lei S, Gao X, et al. PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Clin Sci 2012;122:161-73
   Google Scholar
• Graff JR, McNulty AM, Hanna KR, et al. The protein kinase Cβ-selective inhibitor, enzastaurin (LY317615. HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts. Cancer Res 2005;65:7462-9
   PubMed Web of Science ®Google Scholar
• Ladage D, Tilemann L, Ishikawa K, et al. Inhibition of PKCα/β With Ruboxistaurin Antagonizes Heart Failure in Pigs After Myocardial Infarction Injury Novelty and Significance. Circ Res 2011;109:1396-400
   Google Scholar
• Podar K, Raab MS, Zhang J, et al. Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615. HCl). Blood 2007;109:1669-77
   PubMed Web of Science ®Google Scholar
• Friesner RA, Murphy RB, Repasky MP, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 2006;49:6177-96
   PubMed Web of Science ®Google Scholar
• Jorgensen WL, Tirado RJ. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J Am Chem Soc 1988;110:1657-66
   PubMed Web of Science ®Google Scholar
• Case DA, Darde TA, Cheatham TE, et al. AMBER 11. University of California; San Francisco: 2010
   Google Scholar
• Hornak V, Abel R, Okur A, et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 2006;65:712-25
   PubMed Web of Science ®Google Scholar
• Homeyer N, Horn AH, Lanig H, et al. AMBER force-field parameters for phosphorylated amino acids in different protonation states: phosphoserine, phosphothreonine, phosphotyrosine, and phosphohistidine. J Mol Model 2006;12:281-9
   PubMed Web of Science ®Google Scholar
• Wang J, Wolf RM, Caldwell JW, et al. Development and testing of a general amber force field. J Comput Chem 2004;25:157-74
   Google Scholar
• Piotr C, Wendy DC, Christopher B, et al. Application of the multimolecule and multiconformational RESP methodology to biopolymers: charge derivation for DNA, RNA, and proteins. J Comput Chem 1995;16:1357-77
   Google Scholar
• Jorgensen WL, Chandrasekhar JM, Jd RW, et al. Comparison of Simple Potential Functions for Simulating Liquid Water. J Chem Phys 1983;79:926-35
   Web of Science ®Google Scholar
• Vincent K, Wilfred GVF, Hünenberger PH. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J Comp Chem 2001;22:501-8
   Google Scholar
• Darden T, York D, Pedersen L. Particle Mesh Ewald: an N.Log(N) Method for Computing Ewald Sums. J Chem Phys 1993;98:10089-92
   Web of Science ®Google Scholar
• DeLano WL. The PyMOL molecular graphics system. DeLano Scientific, San Carlos, CA, USA; 2002. Available at: http://www.pymol.org
   Google Scholar
• Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graphics 1996;14:33-8
   PubMed Web of Science ®Google Scholar
• Hou T, Wang J, Li Y, et al. Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking. J Comp Chem 2011;32:866-77
   PubMed Web of Science ®Google Scholar
• Hou T, Wang J, Li Y, et al. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 2011;51:69-82
   PubMed Web of Science ®Google Scholar
• Li L, Li Y, Zhang L, et al. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase. J Chem Inf Model 2012;52:2715-29
   Google Scholar
• Hou T, Li N, Li Y, et al. Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models. J Proteome Res 2012;11:2982-95
   PubMed Web of Science ®Google Scholar
• Xu L, Sun H, Li Y, et al. Assessing the Performance of MM/PBSA and MM/GBSA Methods. 3. The Impact of Force Fields and Ligand Charge Models. J Phys Chem B 2013;117:8408-21
   PubMed Web of Science ®Google Scholar
• Wang J, Hou T, Xu X. Recent advances in free energy calculations with a combination of molecular mechanics and continuum models. Curr Comput Aided Drug Design 2006;2:287-306
   Web of Science ®Google Scholar
• Jörg W, Peter SS, Still WC. Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). J Comput Chem 1999;20:217-30
   Google Scholar
• Massova I, Kollman PA. Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspect Drug Discovery Des 2000;18:113-35
   Google Scholar
• Grewal BK, Sobhia ME. Identification of specific features of inhibition of PKCβII and its potential lead by shape-based virtual screening and molecular docking studies. Bioorg Med Chem Lett 2012;22:4672-7
   Google Scholar
• Kornev AP, Haste NM, Taylor SS, et al. Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism. Proc Natl Acad Sci 2006;47:17783-8
   Google Scholar
• Cristiano GR, Rai BK, Munchhof MJ, et al. Understanding the Impact of the P-loop Conformation on Kinase Selectivity. J Chem Inf Model 2011;51:1199-204
   Google Scholar